RedHill Biopharma Ltd. (RDHL)
NASDAQ: RDHL · Real-Time Price · USD
6.50
+0.03 (0.46%)
At close: Dec 20, 2024, 4:00 PM
6.69
+0.19 (2.92%)
After-hours: Dec 20, 2024, 4:01 PM EST
RedHill Biopharma Market Cap
RedHill Biopharma has a market cap or net worth of $8.32 million as of December 20, 2024. Its market cap has increased by 103.01% in one year.
Market Cap
8.32M
Enterprise Value
1.60M
1-Year Change
103.01%
Ranking
Category
Stock Price
$6.50
Market Cap Chart
Since January 7, 2013, RedHill Biopharma's market cap has decreased from $58.80M to $8.32M, a decrease of -85.84%. That is a compound annual growth rate of -15.08%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 20, 2024 | 8.30M | 76.60% |
| Dec 29, 2023 | 4.70M | -47.78% |
| Dec 30, 2022 | 9.00M | -92.54% |
| Dec 31, 2021 | 120.70M | -57.65% |
| Dec 31, 2020 | 285.00M | 65.51% |
| Dec 31, 2019 | 172.20M | 45.81% |
| Dec 31, 2018 | 118.10M | 34.66% |
| Dec 29, 2017 | 87.70M | -34.06% |
| Dec 30, 2016 | 133.00M | 17.49% |
| Dec 31, 2015 | 113.20M | 31.93% |
| Dec 31, 2014 | 85.80M | 37.28% |
| Dec 31, 2013 | 62.50M | 6.29% |
View and export this data all the way back to 2013.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| COSCIENS Biopharma | 8.55M |
| Viracta Therapeutics | 8.51M |
| Aytu BioPharma | 8.49M |
| QT Imaging Holdings | 8.44M |
| BioCardia | 8.44M |
| Dominari Holdings | 8.23M |
| Virax Biolabs Group | 8.21M |
| CERo Therapeutics Holdings | 8.12M |